Sale of 15,430 shares at $10.7487 per share.
Reporting Person Powl Brian T. · Officer Title Chief Commercial Officer · Transaction Code S
Traded Sep 29, 2026 · Disclosed Sep 29, 2026
Source: SEC Form 4 · 0001193125-26-407935 · filed 2026-09-29 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Kura Oncology, Inc. (KURA)." Disclosed 2026-09-29. https://desqlong.com/cards/0001193125-26-407935-3 (retrieved 2026-09-30).